ZISEBENZA KANJANI IZIHLOKO ze-CBD

I-CBD iyingxenye yesitshalo se-cannabis sativa, esaziwa nangokuthi insangu. I-CBD ayinayo imiphumela ye-psychoactive ngoba iqukethe ngaphansi kwamaphesenti angu-0.3 we-THC. Itholakala ngokhilimu be-topical, ama-lotions, nama-salve, phakathi kwezinye izinhlobo. Uma unenkinga yesikhumba noma uzwa ubuhlungu nokuvuvukala kwemisipha, ukusebenzisa i-CBD ngqo esikhumbeni sakho kuyindlela enhle yokuyithatha ngomlomo.

Uhlolojikelele lwezihloko ze-CBD

Izinkulungwane zeminyaka, izinguqulo ezihlukene ze-CBD balm ye-topical ziye zasetshenziswa ukudambisa izinhlungu nokuvuvukala kanye nokwelapha izifo ezihlukahlukene zesikhumba e-China yasendulo, eNdiya naseLatin America. Uma uke wahlushwa ubuhlungu bemisipha noma isifo sesikhumba esingamahlalakhona, cishe uke wezwa nge-CBD, umuthi osuthandwa kakhulu eminyakeni yamuva nje. I-CBD balm iyindlela yokwelapha yobuhlungu bemvelo ethandwayo kanye nokuvuvukala phakathi kwabasubathi nezimonyo.

Isihloko se-CBD sisebenza kanjani

Isihloko se-CBD asibuvi ubuhlungu noma izimo ezivuvukalayo; esikhundleni salokho, ikhulula ubuhlungu bomzimba futhi inikeza ukukhululeka kobuhlungu bemvelo, okungewona umkhuba. Ukuba khona kwesistimu ye-endocannabinoid emzimbeni kuvumela Izihloko ze-CBD ukwenza kanjalo ngempumelelo. Ingena ezingxenyeni zesikhumba nezingaphansi kwesikhumba, ivumela ukuthi ifinyelele ngaphezu kobuso bayo. Uhlelo lwe-endocannabinoid (ECS), olubhekele ubumnandi nokuhlangenwe nakho kobuhlungu, lwenziwa lusebenze yi-CBD. Lokhu kufezwa ngokunamathisela kuma-cell receptors atholakala ezicutshini ezinemisipha, esikhunjeni nasezinzwa. Ngenxa yalokho, kokubili ubuhlungu nokuvuvukala kungancishiswa.

Izihloko ze-CBD Zisebenza Kanjani Ubuhlungu Nobuhlungu

Ngokusho kukaStuart Titus, i-CEO ye-Medical Marijuana, Inc., i-CBD yesihloko ihlolwe kuphela ngokulinganiselwe. Amakhambi noma ezinye izinto ezingenayo ngokuvamile zisetshenziswa ekwakhiweni kokugcina kwemikhiqizo ye-CBD yesihloko. Ezinye izinto ezifana ne-arnica noma i-menthol zengezwa ukuze kudambise ubuhlungu. Ukugxila kwe-CBD ezixazululweni zezihloko kuvamise ukuba kuncane, futhi umphumela wokuphumuza uthole imiphumela evela kwamanye amakhemikhali. Abathengi kufanele bafunde uhlu lwezingxenye kanye nesitifiketi sokuhlaziya, esibonisa inani eliphelele lama-cannabinoids ahlukile emkhiqizweni. I-COA inikeza imininingwane ngephesenti lesisindo se-CBD ne-THC emikhiqizweni. Iphinde iqinisekise ukuthi umkhiqizo awunazo izibulala-zinambuzane nezinye izinhlanganisela eziyingozi ezinobuthi kubasebenzisi.

Izisombululo ze-CBD ezisezingeni eliphezulu, eziqinile zaziwa ngokunikeza ukudambisa izinhlungu zesikhashana. Ama-Cannabinoid receptors maningi esikhumbeni, futhi i-CBD ivuselela uhlelo lwe-endocannabinoid ngalawo ma-receptors uma isetshenziswa phezulu. I-CBD inamathela kuma-cannabinoid receptors ku-dermis yesikhumba sakho kanye nezingqimba ze-epidermis, ekhulula ubuhlungu nokuvuvukala. I-CBD ye-Topical nayo iyindlela yokwelapha ewusizo yezimo ezimbalwa zesikhumba ngenxa yezakhiwo zayo zokulwa nokuvuvukala.

Isikhumba simunca ngendlela emangalisayo, futhi sizomunca i-CBD eningi kakhulu kuma-topical lotions, ama-gel, namafutha. Hlola izithako ukuze uqinisekise ukuthi azikho izinto ezingezwani nomzimba, uma zimuncwa, ezingaphazamisa nemiyalelo yakho. Xhumana nochwepheshe bezokwelapha.

Kwenzekani Lapho I-Topical CBD Imuncwa Esikhumbeni

Ukukhishwa kwe-CBD kumuncwa esikhunjeni uma kuhlanganiswe nokhilimu we-topical (njenge-topical hemp balm "Soothe." Ukuwugcoba emaqandeni kungase kududuze labo abanobuhlungu besifo samathambo. ukusiza ekudambiseni ubuhlungu bamalunga ezifundweni.Noma kunjalo, i-CBD esetshenziswa esikhunjeni isebenzisa ikhono lemvelo lomzimba lokumunca umsoco ngesikhumba.Ukusebenzisa i-CBD njengesihloko, nokho, kunenye inzuzo.

I-Reactionary Skin Treatments vs. I-Topical Preventative Skin Treatments

Isikhumba sidinga ukunakekelwa okufanele. Nakuba isikhumba sethu siqine ngendlela emangalisayo, sibonakala siwohloka ngenxa yokulimala kweLanga, ukulimala kwamakhemikhali kanye nezinduna.

Odokotela besikhumba khulumela izindlela ezimbili ohlelweni olufanele lwe-skincare ukuze uvimbele futhi unciphise ukulimala kwesikhumba. Ukufaka i-sunscreen ngaphambi kokuphumela ngaphandle kuyisibonelo sokwelashwa kokuvimbela. Isikhumba simbozwe ngama-cannabinoid receptors, amaprotheni akha ingxenye yesistimu ye-endocannabinoid futhi alawule izinqubo zokulala nezinhlungu. Izifundo zokuthi i-CBD isebenzisana kanjani nalawa ma-receptors zisasesigabeni sawo sokuqala. Ucwaningo lwangaphambi kwesikhathi iphakamisa ukuthi i-CBD namanye ama-cannabinoids anomphumela wokulwa nokuvuvukala owaziwa ngokuthi isenzo se-keratinocyte.

Yiziphi Izinzuzo Zezihloko ze-CBD?

Ukuphazamiseka kwesikhumba nobuhlungu nokuvuvukala kungadanjiswa ngokusebenzisa isihloko se-CBD endaweni ethintekile. Ukwelashwa kwe-CBD ye-topical kunciphisa ukuvuvukala okuhlangene kwamagundane, ngokusho kocwaningo lwango-2017. I-CBD ingasiza ekwelapheni izifo zesikhumba njenge-contact dermatitis kanye ne-psoriasis, ngokusho kocwaningo olushicilelwe ku "Umagazini we-American Academy of Dermatology” ngawo lowo nyaka.

Isiphetho

I-CBD namanye ama-cannabinoid receptors maningi emzimbeni. Izihloko ze-CBD namathisela kulawa ma-receptors, okuvumela ukumuncwa kwesikhumba. Ngenxa yalokho, khetha imikhiqizo ye-CBD eyinzuzo kakhulu kuwe nempilo yakho. Ungakwazi ukufeza lokhu ngokucela usizo lochwepheshe noma ngokukhetha izinto ezisetshenziswa kabusha zekhwalithi enhle kakhulu. Ngoba wonke umzimba womuntu uhlukile, abantu abaningi basabela ngendlela ehlukile ezihlokweni ezahlukahlukene ze-CBD.

Okubhekwayo

Cantú, AM (2014). I-Hemp Oil Hustlers.

Del Rosso, JQ (2013). Indima ye-skincare njengengxenye ebalulekile ekulawulweni kwe-acne vulgaris: Ingxenye 1: Ukubaluleka kwezithako zokuhlanza nezokuthambisa, ukwakheka, nokukhethwa komkhiqizo. I-Journal of Clinical and Aesthetic Dermatology, 6(12), i-19.

UWilkinson, JD, & Williamson, EM (2007). Ama-Cannabinoids avimbela ukwanda kwe-keratinocyte yomuntu ngokusebenzisa indlela engeyona ye-CB1/CB2 futhi abe nenani elinamandla lokwelapha ekwelapheni i-psoriasis. Ijenali yesayensi ye-dermatological, 45(2), i-87-92.

Bernhard, JD (2003). Ijenali yehhovisi labahleli le-American Academy of Dermatology. Umagazini we-American Academy of Dermatology, 49(6), i-1028.